Cargando…

Tumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathy

BACKGROUND: While tumor necrosis factor alpha (TNF-α) inhibitors (TNFi) and other biologics are very effective against autoimmune diseases, they can also cause infectious diseases. Therefore, it is important to clarify whether the TNFi sometimes used to treat patients with rheumatoid arthritis (RA)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fukui, Shoichi, Nakamura, Hideki, Takahashi, Yoshiko, Iwamoto, Naoki, Hasegawa, Hiroo, Yanagihara, Katsunori, Nakamura, Tatsufumi, Okayama, Akihiko, Kawakami, Atsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292003/ https://www.ncbi.nlm.nih.gov/pubmed/28158970 http://dx.doi.org/10.1186/s12865-017-0191-2

Ejemplares similares

Absence of HTLV‐II Co‐infection in HTLV‐I‐associated Myelopathy Patients
por: Miyamoto, Kanji, et al.
Publicado: (1992)

Reevaluation for clinical manifestations of HTLV-I-seropositive patients with Sjögren’s syndrome
por: Nakamura, Hideki, et al.
Publicado: (2015)

Tocilizumab has no direct effect on cell lines infected with human T-cell leukemia virus type 1
por: Endo, Yushiro, et al.
Publicado: (2021)

The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Rafatpanah, Houshang, et al.
Publicado: (2013)

Antibodies against p40(tax) Gene Product of Human T‐Lymphotropic Virus Type‐I (HTLV‐I) under Various Conditions of HTLV‐I Infection
por: Kamihira, Shimeru, et al.
Publicado: (1989)

Factors Secreted by Human T Lymphotropic Virus Type I (HTLV-I)–infected Cells Can Enhance or Inhibit Replication of HIV-1 in HTLV-I–uninfected Cells: Implications for In Vivo Coinfection with HTLV-I and HIV-1
por: Moriuchi, Hiroyuki, et al.
Publicado: (1998)

Human T-Lymphotropic Virus (HTLV) Type I in vivo Integration in Oral Keratinocytes
por: Domínguez, Martha C., et al.
Publicado: (2011)

Medical conditions, social and neurological patients of the T-lymphotropic virus humanities-HTLV I
por: Gaspar, GLC, et al.
Publicado: (2014)

A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats
Publicado: (1992)

Human T Lymphotropic Virus Type I (HTLV-I) is a Risk Factor for Coronary Artery Disease
por: Farid Hosseni, Reza, et al.
Publicado: (2013)

Median Nerve Somatosensory Evoked Potential in HTLV-I Associated Myelopathy
por: Boostani, Reza, et al.
Publicado: (2016)

Human T-lymphotropic Virus Type I (HTLV-I) Proviral Load and Clinical Features in Iranian HAM/TSP Patients: Comparison of HTLV-I Proviral Load in HAM/TSP Patients
por: Vakili, Rosita, et al.
Publicado: (2013)

Comparison of HTLV-I Proviral Load in Adult T Cell Leukemia/Lymphoma (ATL), HTLV-I-Associated Myelopathy (HAM-TSP) and Healthy Carriers
por: Akbarin, Mohammad Mehdi, et al.
Publicado: (2013)

Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from the Brazilian Amazon
por: Takatani, Massanobu, et al.
Publicado: (2017)

Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells
por: Usui, Tetsuya, et al.
Publicado: (2008)

HTLV‐I Uveitis: A Distinct Clinical Entity Caused by HTLV‐I
por: Mochizuki, Manabu, et al.
Publicado: (1992)

Detection of HTLV‐I Genome in Seronegative Infants Born to HTLV‐I Seropositive Mothers by Polymerase Chain Reaction
por: Saito, Shigeru, et al.
Publicado: (1989)

High Human T Cell Leukemia Virus Type-1(HTLV-1) Provirus Load in Patients with HTLV-1 Carriers Complicated with HTLV-1-unrelated disorders
por: Sasaki, Daisuke, et al.
Publicado: (2010)

Editorial Commentary: Human T-Cell Lymphotropic Virus Type 1 (HTLV-1) and HTLV-1–Associated Myelopathy/Tropical Spastic Paraparesis
por: Taylor, Graham P.
Publicado: (2015)

Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2020)

Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Burbelo, Peter D, et al.
Publicado: (2008)

Human T-cell lymphotropic virus, type 1 (HTLV-1)-associated myelopathy: MR findings
por: Petscavage, Jonelle M., et al.
Publicado: (2015)

Efficacy of prosultiamine treatment in patients with human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: results from an open-label clinical trial
por: Nakamura, Tatsufumi, et al.
Publicado: (2013)

Induction of galectin-1 expression by HTLV-I Tax and its impact on HTLV-I infectivity
por: Gauthier, Sonia, et al.
Publicado: (2008)

Efficacy of mirabegron for overactive bladder with human T cell lymphotropic virus‐1 associated myelopathy
por: Matsuo, Tomohiro, et al.
Publicado: (2018)

Reduced Tim-3 expression on HTLV-I Tax-specific cytotoxic T lymphocytes in HTLV-I infection
por: Abdelbary, Nashwa H, et al.
Publicado: (2011)

IFN-α(2b) reduces released particles of Human T-lymphotropic Virus-I from HTLV-I transformed cell line
por: Hartoonian, Christine, et al.
Publicado: (2011)

Adult T-Cell Lymphoma (ATL) With Erythroderma in Indolent Human T-Lymphotropic Virus Type I (HTLV-1) Infection
por: Qasim, Abeer, et al.
Publicado: (2023)

HAM/TSP Pathogenesis: The Transmigration Activity of HTLV-1-Infected T Cells into Tissues
por: Nakamura, Tatsufumi
Publicado: (2023)

Novel Complications with HTLV‐1‐associated Myelopathy/Tropical Spastic Paraparesis: Interstitial Cystitis and Persistent Prostatitis
por: Nomata, Koichiro, et al.
Publicado: (1992)

Increased Prevalence of HTLV‐I Infection in Patients with Hepatocellular Carcinoma Associated with Hepatitis C Virus
por: Okayama, Akihiko, et al.
Publicado: (1995)

Is there any Association Between Human Lymphotropic Virus Type I (HTLV-I) Infection and Systemic Lupus Erythematosus? An Original Research and Literature Review
por: Shirdel, Abbas, et al.
Publicado: (2013)

Designing a Human T-Lymphotropic Virus Type 1 (HTLV-I) Diagnostic Model using the Complete Blood Count
por: Sarbaz, Masoumeh, et al.
Publicado: (2013)

HTLV-1 Infection and Rheumatic Diseases
por: Umekita, Kunihiko, et al.
Publicado: (2020)

Evaluation of Elecsys HTLV‐I/II assay in comparison with ARCHITECT rHTLV‐I/II assay with Korean samples
por: Yun, Seung Gyu, et al.
Publicado: (2019)

HUMAN T-LYMPHOTROPIC VIRUS 1 (HTLV-1) AND HUMAN T-LYMPHOTROPIC VIRUS 2 (HTLV-2): GEOGRAPHICAL RESEARCH TRENDS AND COLLABORATION NETWORKS (1989-2012)
por: GONZÁLEZ-ALCAIDE, Gregorio, et al.
Publicado: (2016)

Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis
Publicado: (1994)

Human T Lymphotropic Virus Type I (HTLV-I) Oncogenesis: Molecular Aspects of Virus and Host Interactions in Pathogenesis of Adult T cell Leukemia/Lymphoma (ATL)
por: Ahmadi Ghezeldasht, Sanaz, et al.
Publicado: (2013)

NFkB activation promotes immune activation in HTLV-I-associated myelopathy / tropical spastic paraparesis
por: McCormick, Matthew, et al.
Publicado: (2011)

Southernmost Carriers of HTLV‐I/II in the World
por: Cartier, Luis, et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_5a43f4lt9d132sf5vsto9bhllo